• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Mucopolysaccharidosis Type VII

Mucopolysaccharidosis Type VII - 4 Studies Found

Completed : Biomarker for Sly Disease
:
  • Mucopolysaccharidosis VII
  • Sly Disease : 2014-10-23
Completed : A Phase 3 Study of UX003 rhGUS Enzyme Replacement Therapy in Patients With MPS 7
:
  • MPS 7
  • Sly Syndrome
  • : 2014-08-22
    :
    • Drug: UX003 UX003 is a sterile

Active, not recruiting : A Long-Term Open-Label Treatment and Extension Study of UX003 rhGUS Enzyme Replacement Therapy in Subjects With MPS 7
:
  • Sly Syndrome
  • MPS VII
  • : 2015-04-22
    : Drug: UX003 UX003 is a sterile liquid buffered saline formulation of rhGUS that contains enzyme at a con
Active, not recruiting : An Open-Label Study of UX003-rhGUS Enzyme Replacement Treatment in MPS 7 Patients Less Than 5 Years of Age
:
  • Sly Syndrome
  • MPS VII
  • : 2015-04-12
    : Drug: UX003 Other Names:
    • recombinant human beta-glucoronidase

Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.